Search Results for “Dupilumab” – Page 3 – Endpoints News

SIGN UP

search results for: Dupilumab

That turnaround on new FDA drug approvals? We’re right on schedule

8 years ago

With a competitive Bill Sibold taking the helm at Sanofi Genzyme, longtime exec David Meeker makes an exit

8 years ago

Regeneron and Sanofi land the big one, winning FDA approval for their megablockbuster hopeful Dupixent

8 years ago

Sanofi and Regeneron score early access for dupilumab in UK; Sanders skewers Sanofi on Zika vaccine

8 years ago

Regeneron, Sanofi, get ready to duke it out with Pfizer over a megablockbuster eczema market

8 years ago

Playing catch-up, Regeneron and Sanofi push ahead on pivotal PD-1 cancer studies

8 years ago

Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout

8 years ago

Pfizer racks up an FDA approval for eczema blockbuster hopeful crisaborole

8 years ago

Sanofi jumps into a pivotal study for next-gen Pompe drug

8 years ago

Manufacturing woes derail a blockbuster contender from Sanofi/Regeneron. Who's next?

8 years ago

FDA flashes red light on Sanofi manufacturing infraction, threatening a looming blockbuster decision

8 years ago

Blockbuster performance: Regeneron, Sanofi add stellar PhIII dupilumab data on display at EADV

8 years ago

Regeneron, Sanofi win red-carpet treatment at the FDA for a blockbuster contender

8 years ago

AstraZeneca offers some mixed PhIII results for severe asthma, while Roche rival flounders

8 years ago

Thumbs Up/Thumbs Down: The new buzz in R&D, blockbuster work on a budget and why what’s dead may never die

8 years ago

Regeneron makes a blockbuster case for its PhIII drug pipeline

8 years ago

The 15 top R&D spenders in the global biopharma business: 2016

8 years ago

Scoring the 5 top phase III drugs in the global pipeline

8 years ago

First page Previous page 1 23

latest

Most read

J&J's AI head jumps to Recursion; Doug Williams resigns as Sana's R&D chief

22 hours ago

Takeda wins label expansion for subcutaneous Entyvio, creating 'flexibility' for Crohn's patients

15 hours ago

CSL Vifor proposes a marketing campaign to settle European Commission investigation

15 hours ago

Senators want to know more on why Novo is discontinuing its insulin Levemir

15 hours ago

Califf talks bolstering domestic drug manufacturing, foreign inspections at House hearing

16 hours ago

see latest stream